Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy

Institute of Liver and Biliary Sciences, India

Status: Withdrawn

Conditions: CKD With Hepatitis C

Study type: Observational

Funder types: Other

Identifiers

NCT02563665

ILBS-HCKD/001/SOFO/2015

Details and patient eligibility

About

All patients with chronic kidney disease (stages 3, 4 and 5) and chronic dialysis patients with HCV infection attending nephrology and Hepatology OPD or getting outpatient dialysis at the dialysis unit of ILBS.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients with moderate to severe renal dysfunction (CKD stage 3, 4, 5) and chronic dialysis patients
2. Patients consented for the study protocol by signing the informed consent.

Exclusion criteria

1. Age less than 18 years
2. Confirmed pregnancy
3. HCV-HIV Co infection
4. HBV-HCV co infection

Trial design

0 participants in 2 patient groups

advanced chronic kidney disease

Description:

Subjects on dialysis with GFR (Glomerular Filtration Rate) \> 30

Renal replacement therapy.

Description:

Subjects who are not on dialysis with GFR (Glomerular Filtration Rate) \< 15